Acropectorovertebral dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:957OMIM:102510Q74.8
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acropectorovertebral dysplasia, also known as F syndrome or Acropectorovertebral syndrome, is a rare congenital malformation syndrome primarily affecting the skeletal system. The condition was first described by Dundar et al. and is characterized by a distinctive combination of limb, chest, and spinal anomalies. Key features include fusion of the fingers and toes (syndactyly), particularly involving a characteristic fusion pattern in the hands that may resemble a mitten-like appearance, along with preaxial polydactyly (extra digits on the thumb side). Chest wall abnormalities, including pectus carinatum or other sternal malformations, and vertebral segmentation defects affecting the spine are also hallmark features of the condition. The skeletal abnormalities are present from birth and may vary in severity even among affected members of the same family. Additional features can include carpal and tarsal bone fusions, synostosis (abnormal bony fusion) of various bones, and spina bifida occulta. The upper limbs tend to be more severely affected than the lower limbs. Intelligence and cognitive development are typically normal in affected individuals. There is no specific cure or targeted therapy for acropectorovertebral dysplasia. Management is primarily supportive and symptomatic, focusing on orthopedic interventions. Surgical correction of syndactyly and polydactyly may be performed to improve hand function and appearance. Spinal abnormalities may require monitoring and, in some cases, orthopedic management to prevent complications such as scoliosis. Genetic counseling is recommended for affected families given the hereditary nature of the condition.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Apr 2026"F!reF!ghterF!t": Lifestyle Coaching Interventions for Obese Firefighters (FireFit)

Cambridge Health Alliance — NA

TrialNOT YET RECRUITING
Feb 2026Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region

Medical University of Vienna

TrialRECRUITING
Jan 2026Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot

Medical University of South Carolina — NA

TrialRECRUITING
Dec 2025Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)

University of California, Davis — EARLY_PHASE1

TrialRECRUITING
Oct 2025f-ESWT vs Steroid Injection for Piriformis Syndrome

Gulhane Training and Research Hospital

TrialNOT YET RECRUITING
May 2025Translation and Validation of the French mPCOSQ (mPCOSQ-F).

CHU de Reims

TrialRECRUITING
Feb 2025Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation

National Center for AIDS/STD Control and Prevention, China CDC — PHASE4

TrialNOT YET RECRUITING
May 2024The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study

McGill University Health Centre/Research Institute of the McGill University Health Centre — PHASE4

TrialNOT YET RECRUITING
Jun 2023Incidence and Factors Associated to the Development of PICS-F Among ICU Relatives: A Longitudinal Exploratory Study

Pontificia Universidad Catolica de Chile

TrialRECRUITING
Jul 2022Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported

Centre Hospitalier Universitaire de Saint Etienne

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Acropectorovertebral dysplasia.

View clinical trials →

No actively recruiting trials found for Acropectorovertebral dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acropectorovertebral dysplasia community →

Specialists

3 foundView all specialists →
LM
Lynnette K Nieman, M.D.
BETHESDA, MD
Specialist
PI on 9 active trials
OP
Oliver W. Press, MD, PhD
SAN LUIS OBISPO, CA
Specialist
PI on 4 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acropectorovertebral dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acropectorovertebral dysplasiaForum →

No community posts yet. Be the first to share your experience with Acropectorovertebral dysplasia.

Start the conversation →

Latest news about Acropectorovertebral dysplasia

Disease timeline:

New recruiting trial: Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Imaging Immune Activation in HIV by PET-MR

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Imaging Immune Activation in COVID-19

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Translation and Validation of the French mPCOSQ (mPCOSQ-F).

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Incidence and Factors Associated to the Development of PICS-F Among ICU Relatives: A Longitudinal Exploratory Study

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

New recruiting trial: Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)

A new clinical trial is recruiting patients for Acropectorovertebral dysplasia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acropectorovertebral dysplasia

What is Acropectorovertebral dysplasia?

Acropectorovertebral dysplasia, also known as F syndrome or Acropectorovertebral syndrome, is a rare congenital malformation syndrome primarily affecting the skeletal system. The condition was first described by Dundar et al. and is characterized by a distinctive combination of limb, chest, and spinal anomalies. Key features include fusion of the fingers and toes (syndactyly), particularly involving a characteristic fusion pattern in the hands that may resemble a mitten-like appearance, along with preaxial polydactyly (extra digits on the thumb side). Chest wall abnormalities, including pectus

How is Acropectorovertebral dysplasia inherited?

Acropectorovertebral dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acropectorovertebral dysplasia typically begin?

Typical onset of Acropectorovertebral dysplasia is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Acropectorovertebral dysplasia?

3 specialists and care centers treating Acropectorovertebral dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.